Anticoagulation in Patients with End-Stage Renal Disease and Atrial Fibrillation: Confusion, Concerns and Consequences
Narender Goel, Deepika Jain, Danny B. Haddad, Divya Shanbhogue
J Stroke. 2020;22(3):306-316.   Published online 2020 Sep 29     DOI: https://doi.org/10.5853/jos.2020.01886
Citations to this article as recorded by Crossref logo
Kidney Function and the Use of Vitamin K Antagonists or Direct Oral Anticoagulants in Atrial Fibrillation
Dolina Gencheva
Journal of Cardiovascular Emergencies.2023; 9(3): 49.     CrossRef
The safety and efficacy of direct oral anticoagulants among chronic kidney disease patients on dialysis with non-valvular atrial fibrillation: a meta-analysis
Jerahmeel Aleson L. Mapili, Lloyd Christopher S. Lim, Bianca M. Velando, Jaime Alfonso M. Aherrera
Frontiers in Cardiovascular Medicine.2023;[Epub]     CrossRef
Apixaban reduces the risk of major and clinically relevant non-major bleeding compared to warfarin in patients with end stage renal disease; a systematic review and meta-analysis of ten studies
Konstantinos Zagoridis, Lazaros Karatisidis, Theodoros Mprotsis, Aikaterini Pentidou, Zoi Bezirgianidou, Christina Misidou, Emmanouil Spanoudakis
Thrombosis Research.2023; 231: 17.     CrossRef
Use of Non-Vitamin K Dependent Oral Anticoagulant in Ischemic Stroke
Hyungjong Park, Joonsang Yoo
Journal of the Korean Neurological Association.2022; 40(1): 1.     CrossRef
S2k-Leitlinie: Sekundärprophylaxe ischämischer Schlaganfall und transitorische ischämische Attacke (TIA) – Teil 1 und Teil 2
Gerhard F. Hamann, D. Sander, Armin Grau, J. Röther
DGNeurologie.2022; 5(5): 369.     CrossRef
Diabetes und kardiovaskuläre Ereignisse
Harald Darius
Diabetes aktuell.2022; 20(05): 223.     CrossRef
Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis
Wenhao Li, Yanxia Zhou, Siqi Chen, Dewang Zeng, Haidong Zhang
Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
Choosing the right chronic medication for hemodialysis patients. A short ABC for the dialysis nephrologist
Clarisse Roux, Kristelle Verollet, Julien Prouvot, Camelia Prelipcean, Emilie Pambrun, Olivier Moranne
Journal of Nephrology.2022; 36(2): 521.     CrossRef
Antithrombotic therapy in diabetes: which, when, and for how long?
Ramzi A Ajjan, Noppadol Kietsiriroje, Lina Badimon, Gemma Vilahur, Diana A Gorog, Dominick J Angiolillo, David A Russell, Bianca Rocca, Robert F Storey
European Heart Journal.2021; 42(23): 2235.     CrossRef
Many Good Reasons to Switch from Vitamin K Antagonists to Non-Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation
Giovanni Luca Botto, Pietro Ameri, Raffaele De Caterina
Journal of Clinical Medicine.2021; 10(13): 2866.     CrossRef

Hemoperitoneum After Cardiopulmonary Resuscitation in Peritoneal Dialysis Patients: A Tale of Two Cases

Narender Goel, Danny B Haddad, Deepika Jain
International Journal of Nephrology and Renovascular Disease.2020; Volume 13: 379.     CrossRef